Research programme: glucagon-like peptide-1 receptor modulators - Rezolute

Drug Profile

Research programme: glucagon-like peptide-1 receptor modulators - Rezolute

Alternative Names: AB201

Latest Information Update: 08 Dec 2017

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator AntriaBio
  • Developer Rezolute
  • Class Glucagon-like peptides
  • Mechanism of Action Glucagon-like peptide 1 receptor modulators
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity Yes

Highest Development Phases

  • No development reported Diabetes mellitus

Most Recent Events

  • 07 Dec 2017 AntriaBio is now called Rezolute
  • 16 Jul 2016 No recent reports of development identified for research development in Diabetes-mellitus in USA
  • 11 Jan 2013 Early research in Diabetes mellitus in USA (unspecified route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top